Abstract
Hazard identification for risk assessment of nanoparticles (NPs) is mainly composed of in vitro cell-based assays and in vivo animal experimentation. The rapidly increasing number and functionalizations of NPs makes in vivo toxicity tests undesirable on both ethical and financial grounds, creating an urgent need for development of in vitro cell-based assays that accurately predict in vivo toxicity and facilitate safe nanotechnology.
Original language | English |
---|---|
Pages (from-to) | 55 |
Journal | Particle and Fibre Toxicology |
Volume | 10 |
Issue number | 1 |
DOIs | |
Publication status | Published - 25 Oct 2013 |